VNDA icon

Vanda Pharmaceuticals

88 hedge funds and large institutions have $187M invested in Vanda Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 88 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
+88
Holders Change %
% of All Funds
2.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
88
Increased
Reduced
Closed
Calls
$15.4M
Puts
$3.89M
Net Calls
+$11.5M
Net Calls Change
+$11.5M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Shares
Change %
GGHC
76
Gilder Gagnon Howe & Co
New York
$91K +$91K +11,264 New
AAP
77
Ardsley Advisory Partners
Connecticut
$81K +$81K +10,000 New
FANJ
78
Financial Architects (New Jersey)
New Jersey
$80K +$80K +10,000 New
Barclays
79
Barclays
United Kingdom
$76K +$76K +9,429 New
SO
80
STRS Ohio
Ohio
$72K +$72K +8,900 New
Citigroup
81
Citigroup
New York
$21K +$21K +2,507 New
Ameriprise
82
Ameriprise
Minnesota
$17K +$17K +2,197 New
EWM
83
Edge Wealth Management
New York
$16K +$16K +2,000 New
BlackRock
84
BlackRock
New York
$7K +$7K +907 New
Wells Fargo
85
Wells Fargo
California
$4K +$4K +552 New
PFG
86
Piershale Financial Group
Illinois
$1K +$1K +101 New
First Manhattan
87
First Manhattan
New York
$1K +$1K +200 New